Login to Your Account


Series A investments boost 2013 for VC-backed biopharmas

By Brian Orelli
Contributing Writer

Monday, January 6, 2014

U.S. biopharmaceutical companies capped 2013 with the strongest quarter of the year, raising $835 million in 37 venture capital deals in the fourth quarter according to data compiled by BioWorld Snapshots.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription